Kenaikan C-Reactive Protein pada Remaja Gangguan Bipolar: A Systematic Review
DOI:
https://doi.org/10.54259/sehatrakyat.v5i2.7236Keywords:
C-Reactive Protein, Inflammation, Adolescents, Bipolar DisorderAbstract
The diagnosis of bipolar disorder (BD) in adolescents is often delayed due to reliance on subjective assessments, necessitating objective biomarkers such as C-reactive protein (CRP) to improve clinical accuracy. This systematic review aims to synthesize the latest findings on the role of CRP levels in adolescents with BD through analysis of various experimental studies. The systematic review was conducted in January 2026 through searches in Embase, PubMed, and ScienceDirect for studies from 2016 to 2025. Selection was performed according to PRISMA. Risk of bias was assessed using JBI Critical Appraisal Tools. A total of four experimental studies with a total of 3298 subjects met the criteria with low to moderate risk of bias. CRP levels in adolescents with Bipolar Disorder were found to be significantly elevated compared to the control group, especially during the symptomatic phase and periods of severe symptoms. CRP levels in adolescents with BD were found to be significantly elevated compared to healthy controls (p<0.001) and the anxiety disorder group, especially during the severe symptomatic phase. Additionally, high initial CRP levels significantly predicted longer recovery times (p=0.009). CRP is an effective state-dependent biomarker to support diagnostic accuracy, predict clinical course, and monitor the risk of cognitive decline in adolescents with BD.
Downloads
References
Chan, J. K. N., Wong, C. S. M., Yung, N. C. L., Chen, E. Y. H., & Chang, W. C. (2021). Excess mortality and life-years lost in people with bipolar disorder: an 11-year population-based cohort study. Epidemiology and Psychiatric Sciences, 30, e39. https://doi.org/10.1017/S2045796021000305
Cuomo, A., Koukouna, D., Spiti, A., Barillà, G., Goracci, A., Bolognesi, S., & Fagiolini, A. (2021). Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.803034
Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024). Inflammation as common link to progressive neurological diseases. Archives of Toxicology, 98(1), 95–119. https://doi.org/10.1007/s00204-023-03628-8
Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., & Berk, M. (2016). C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. The Lancet Psychiatry, 3(12), 1147–1156. https://doi.org/10.1016/S2215-0366(16)30370-4
Huang, M., Chan, Y. E., Chen, M., Hsu, J., Huang, K., Li, C., Tsai, S., Su, T., & Bai, Y. (2023). A longitudinal study of the association between pro‐inflammatory cytokines and mood symptoms in bipolar disorder. Acta Psychiatrica Scandinavica, 147(1), 81–91. https://doi.org/10.1111/acps.13508
Karthikeyan, S., Dimick, M. K., Fiksenbaum, L., Jeong, H., Birmaher, B., Kennedy, J. L., Lanctôt, K., Levitt, A. J., Miller, G. E., Schaffer, A., Young, L. T., Youngstrom, E. A., Andreazza, A. C., & Goldstein, B. I. (2022). Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study. Brain, Behavior, and Immunity, 100, 278–286. https://doi.org/10.1016/j.bbi.2021.11.020
McIntyre, R. S., Alda, M., Baldessarini, R. J., Bauer, M., Berk, M., Correll, C. U., Fagiolini, A., Fountoulakis, K., Frye, M. A., Grunze, H., Kessing, L. V., Miklowitz, D. J., Parker, G., Post, R. M., Swann, A. C., Suppes, T., Vieta, E., Young, A., & Maj, M. (2022). The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry, 21(3), 364–387. https://doi.org/10.1002/wps.20997
Phillips, M. L., & Kupfer, D. J. (2013). Bipolar disorder diagnosis: challenges and future directions. The Lancet, 381(9878), 1663–1671. https://doi.org/10.1016/S0140-6736(13)60989-7
Poletti, S., Mazza, M. G., & Benedetti, F. (2024). Inflammatory mediators in major depression and bipolar disorder. Translational Psychiatry, 14(1), 247. https://doi.org/10.1038/s41398-024-02921-z
Pratiwi, A. F., & Herdaetha, A. (2022, September). Case Report: Bipolar Type 1 Affective Disorder in The 25 Years Old Male. Proceeding of 15th Continuing Medical Education.
Rahmani, N., Hatch, J., Dimick, M., Naiberg, M. R., Fiksenbaum, L., Andreazza, A. C., Bowie, C. R., Dickstein, D. P., & Goldstein, B. I. (2021). Lower pro- to anti-inflammatory ratios associated with reduced neurocognitive flexibility in symptomatic adolescents with bipolar disorder. Journal of Affective Disorders, 292, 430–438. https://doi.org/10.1016/j.jad.2021.05.062
Ríos, U., Pérez, S., Martínez, C., Moya, P. R., & Arancibia, M. (2025). Inflammation and Cognition in Bipolar Disorder: Diverging Paths of Interleukin-6 and Outcomes. International Journal of Molecular Sciences, 26(13), 6372. https://doi.org/10.3390/ijms26136372
Shaker, Z., Goudarzi, Z., Ravangard, R., Shaker, Z., Hedayati, A., & Keshavarz, K. (2024). The economic burden of bipolar disorder: a case study in Southern Iran. Cost Effectiveness and Resource Allocation, 22(1), 55. https://doi.org/10.1186/s12962-024-00560-1
Singh, B., Swartz, H. A., Cuellar-Barboza, A. B., Schaffer, A., Kato, T., Dols, A., Sperry, S. H., Vassilev, A. B., Burdick, K. E., & Frye, M. A. (2025). Bipolar disorder. The Lancet, 406(10506), 963–978. https://doi.org/10.1016/S0140-6736(25)01140-7
Syahrizal, Eljatin, M. R. A., Yurnailis, & Lubis, N. H. (2024). Penatalaksanaan Gangguan Afektif BipolarEpisode Kini Depresif Berat tanpa Gejala Psikotik melalui Pendekatan Kedokteran Keluarga. Jurnal Pengabdian Masyarakat Bidang Sains Dan Teknologi, 3(1).
Viehmann-Wical, K., Lee, J. W., Wiafe, S. A., Sathananthan, M., & Nelson, A. (2022). Elevated C-Reactive Protein: An Inflammation Indicator Due to Low-Quality Sleep. Pan-African Journal of Health and Environmental Science, 1(1).
Whitney, M. S., Scott, S. L., Perez, J. A., Barnes, S., & McVoy, M. K. (2022). Elevation of C-reactive protein in adolescent bipolar disorder vs. anxiety disorders. Journal of Psychiatric Research, 156, 308–317. https://doi.org/10.1016/j.jpsychires.2022.09.019
World Health Organization. (2025, March 31). Bipolar disorder. https://www.who.int/news-room/fact-sheets/detail/bipolar-disorder
Zannah, U., Puspitasari, I. M., & Sinuraya, R. K. (2018). Review: Farmakoterapi Gangguan Bipolar. Farmaka, 16(1).
Zhan, Y., Tong, Y., Jiao, T., Zhang, W., Wu, X., Wang, Z., & Zhang, G. (2026). The burden of bipolar disorder in adolescents and young adults: A global, regional, and national perspective from 1990 to 2021 with projections to 2040. Journal of Affective Disorders, 394, 120463. https://doi.org/10.1016/j.jad.2025.120463
Zhong, Y., Chen, Y., Su, X., Wang, M., Li, Q., Shao, Z., & Sun, L. (2024). Global, regional and national burdens of bipolar disorders in adolescents and young adults: a trend analysis from 1990 to 2019. General Psychiatry, 37(1), e101255. https://doi.org/10.1136/gpsych-2023-101255
Zou, Y., Grigorian, A., Karthikeyan, S., & Goldstein, B. I. (2022). Elevated C-reactive protein among symptomatic youth with bipolar disorder. Journal of Psychopharmacology, 36(5), 645–652. https://doi.org/10.1177/02698811221093796
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ulil Albab Habibah, Satria Akbar Putra Asmara, Triyana Indah Purwati, Nisrina Nabila
This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATRAKYAT (Jurnal Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATRAKYAT (Jurnal Kesehatan Masyarakat).
